Moelis & Co MC 深 沪
等待开盘 11-06 09:30:00 美东时间
58.115
-3.235
-5.27%
华盛通- 最 高61.965
- 今 开61.73
- 成交量 113.11万股
- 最 低 57.135
- 昨 收 61.35
- 总市值 43.05亿
- 52周最高 76.2662
- 市盈率 静 19.76
- 换手率 1.53%
- 52周最低 49.76
- 委 比 -61.54%
- 总股本 7408.09万
- 历史最高 78.34
- 量 比 1.12
- 振 幅 7.87%
- 历史最低 -13.6925
- 每 手 1
- 风险率 5.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Moelis & Co收涨4.08%，成交额6716.02万美元
11月3日，Moelis & Co（MC）收涨4.08%，报60.98美元，成交额6716.02万美元，市值45.35亿美元。 行情数据 • 开盘价：...
11-03 06:07
Stifel Expands Leadership in Capital Solutions with Three Senior Hires
Stifel Financial Corp. has appointed Adam Steinberg, Mickey Brunton, and Gavin Kolt as Managing Directors to strengthen its Capital Solutions platform. Steinberg leads Capital Structure Advisory, Brunton co-leads GP-Led Secondaries, and Kolt heads Private Capital Markets. These additions enhance Stifel's ability to provide comprehensive financing and advisory services to corporate and financial sponsor clients.
11-02 13:30
美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
JP Morgan Maintains Neutral on Moelis, Lowers Price Target to $68
JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:MC) with a Neutral and lowers the price target from $70 to $68.
10-28 03:30
Moelis & Co收跌0.96%，成交额3463.77万美元
10月24日，Moelis & Co（MC）收跌0.96%，报54.53美元，成交额3463.77万美元，市值40.56亿美元。 行情数据 • 开盘价...
10-24 05:12
Moelis & Co收跌1.39%，成交额6925.21万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:11
Pilgrim's Pride forms special committee to advise on JBS proposal
Pilgrim's Pride (PPC) said its board formed a special committee of independent and disinterested directors to review and evaluate the previously announced unsolicited proposal from JBS (JBS) in August...
10-09 23:05
美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
Goldman Sachs Maintains Neutral on Moelis, Lowers Price Target to $62
Goldman Sachs analyst James Yaro maintains Moelis (NYSE:MC) with a Neutral and lowers the price target from $71 to $62.
10-02 01:19
